Zymeworks (NASDAQ-ZYME) Stock Price Today • Wrapstocks

$8.69

24H

1.86%

Market Cap

612.9 M

Volume

325.9 K

Supply

70.6 M

Price Chart

About Zymeworks - ZYME

Zymeworks Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially for the treatment of cancer. They are known for their proprietary platforms which can develop bispecific antibodies and other protein-based therapeutics.

Zymeworks Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of next-generation multifunctional biotherapeutics. Their core values and mission emphasize leveraging their proprietary technology platforms to create innovative therapies designed to improve patients' lives who are suffering from complex diseases.

Zymeworks Inc. was founded by Ali Tehrani, Anthony Fejes, and Nick Bedford in 2003.

The CEO leads Zymeworks Inc.; however, for the most current information on the company's leadership, please refer to their official website or latest corporate announcements.

Zymeworks Inc. is headquartered in Vancouver, British Columbia, Canada. Its base country is Canada.

Zymeworks Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "ZYME" and on the Toronto Stock Exchange (TSX) under the same ticker symbol.

Zymeworks (ZYME) Price Live Data

The live price of Zymeworks (ZYME) is $8.69, with a trading volume of 325,852 in the last 24 hours. Wrapstocks updates the ZYME price in real-time. Zymeworks is down -1.86% in the last 24 hours. The company has a live market cap of $612,884,864.00 and a supply of 70,568,205 ZYME stocks.

Zymeworks (ZYME) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 1 hour and 13 minutes.

NASDAQ

NASDAQ Stock Exchange